Compare QURE & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QURE | PWP |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2013 | 2020 |
| Metric | QURE | PWP |
|---|---|---|
| Price | $17.61 | $21.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 3 |
| Target Price | ★ $44.92 | $23.50 |
| AVG Volume (30 Days) | ★ 1.6M | 731.6K |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | 29.67 | ★ 138.52 |
| EPS | N/A | ★ 0.47 |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $31.87 |
| Revenue Next Year | $200.43 | $16.54 |
| P/E Ratio | ★ N/A | $45.89 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $14.99 |
| 52 Week High | $71.50 | $25.93 |
| Indicator | QURE | PWP |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 74.20 |
| Support Level | $13.47 | $20.70 |
| Resistance Level | $18.37 | $23.01 |
| Average True Range (ATR) | 1.33 | 0.86 |
| MACD | 0.27 | 0.46 |
| Stochastic Oscillator | 87.86 | 78.61 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.